Member Info for Sangijuelas1

Oliveira sells due to end
Buyers waiting in the wings
Shorts will be closing
Results due for 0518 Blockbuster Drug

Apparently you can pick up NFTs of Ant Mwahs 4D charts on ebay

Also on their list of deals was Calporta Therapeutics with pre clinical Parkinsons drugs so Merck are very interested in Parkinsons

Their partnership with Yumanity is interesting as Yumanity triggered a milestone payment from pre clinical research in Parkinsons.

Michael J Fox Foundation also involved with them.

There are a lot of synergies with what 4D and Merck do. Oncology, Parkinsons, Vaccines and Asthma, IBS.

It's probably a bit difficult for them to justify spending a massive amount on 4D relative to the current ridiculous Mcap

You will see ArQule on the list. They were also financed with a loan from Oxford

When John Doyle was appointed CFO the post was liked on LinkedIn by Michel de Baar who is Executive Director of Merck Business Development and Licensing in Europe specialising in infectious disease, immunology and vaccines.

They are the people that make the deals at Merck.

https://www.msdlicensing.com/

Here are the most recent deals
https://www.msdlicensing.com/news/

Also missed is that it is a major validation of the Micro RX platform since the Exploratory Science Center are actually using it themselves

I think a lot of people missed the significance of them going from the discovery phase to the pre clinical.

Think it was flagged in September but could have actually happened earlier. Maybe a Phase 1 trial is in the offing?

I posted a lot of stuff recently about the vaccines program , especially the fact that they are Nasal vaccine adjuvants most likely for dendritic cell vaccines.

Also that cancer could be being targeted. HIV is also a big focus at the Exploratory Science Center.

Obviously the $1bn milestones would be for all 3 candidates to get through to approval.

But the deal is due to expire in October unless extended.

And you would wonder why MSD would do a fireside chat with 4D at a conference discussing the benefits of partnerships between small and large pharma.

https://mobile.twitter.com/4dpharmaplc/status/1441356990911946755?cxt=HHwWhoCp3f2i3YAoAAAA

Interesting interview with Daria Hazuda with regard to the Exploratory Science Center and their main focus on the microbiome derived live biotherapeutics, immuno oncology and vaccines.

https://www.nature.com/articles/d41573-019-00091-y

Their centre in London is focused on ageing and neuro degenerative disease.

You would wonder why MSD have said stuff like this

Daria Hazuda, Chief Scientific Officer of MSD’s Exploratory Science Center and MSD’s Vice President of Infectious Diseases and Vaccines Discovery Research, commented: “A key element of our focus in the Exploratory Science Center is the evaluation of emerging new areas of biology that have the potential to offer major beneficial impact to human health. By applying 4D’s MicroRx® technology we hope to gain meaningful insights into the role for the host microbiome in modulating the immune response and ultimately protection conferred by vaccines.”

Merck is Mcap is approximately 2370 times the value of 4D

And yet they bothered to buy 5% of the company and one of their scientists is closely involved on the 0518 trial team.

And they are using 4D candidates for pre clinical work on nasal vaccines

You would wonder why they would get involved with such a minnow like 4D

Ed sold half his holding after reading one of Crls posts and I nearly blew my brains out

And scaremongering with stories about WW3

Do your own research.

We all get the blatant derampers like Truant but some are much more subtle and look to wear you down by telling you continually how much money they have lost on share dealing.

I just hope folks here are able to evaluate what good results would look like.

As the derampers would no doubt be along very quickly to tell you they are terrible.

If 0518 is good, you won't have to worry about any short term SP rise.

Just sit back and wait for the buyout.

The guy is a privileged entitled twat who contributes nothing apart from trying to oldmansplain things to people who no doubt he views as inferior mortals

I have to mute you as well robins as you are pretty dreary to.

Despite the merits of Blautix 0518 has the potential to be a blockbuster across multiple cancer types and at the various stages of treatment in different combos or even as a monotherapy

I meant the need to prioritise 0518 not Blautix